z-logo
Premium
Study of isotope effects on protein binding by gas chromatography/mass spectrometry of theophylline–phenobarbitone and 2 H, 13 C, 15 N isotopomers
Author(s) -
Cherrah Y.,
Falconnet J. B.,
Desage M.,
Brazier J. L.,
Zini R.,
Tillement J. P.
Publication year - 1988
Publication title -
biomedical and environmental mass spectrometry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.475
H-Index - 121
eISSN - 1096-9888
pISSN - 0887-6134
DOI - 10.1002/bms.1200170403
Subject(s) - theophylline , chemistry , human serum albumin , isotopomers , mass spectrometry , chromatography , tryptophan , isotope , kinetic isotope effect , organic chemistry , biochemistry , amino acid , molecule , deuterium , pharmacology , medicine , physics , quantum mechanics
Abstract We describe a comparative study of human serum albumin (HSA) binding by equilibrium dialysis (pH 7.4, 37°C, 3 h) for two groups of isotopic analogues: theophylline and 1‐C( 2 H 3 )theophylline; unlabelled, 5(ethyl( 2 H 5 )),‐5(phenyl( 2 H 5 )) and 1,3‐ 15 N;2‐ 13 C‐phenobarbitone. Bound and free drug fractions are quantified by combined gas chromatography/mass spectrometry. In three instances, protein binding parameters are greatly affected by isotopic substitution, namely for: theophylline and 1‐C( 2 H 3 )theophylline with isotope effects on total binding site concentration ( N ), affinity constant ( K a ) and extent of HSA binding (%) respectively, equal to: N L /N H =0.51; K aL /K aH = 1.78; %L/%H = 0.96 (L (light) and H (heavy) represent the unlabelled and labelled analogue respectively); phenobarbitone/‐5‐(phenyl( 2 H 5 ))phenobarbitone, N L /N H = 1.72; K aL / K aH = 0/56; %L/%H = 1.26; phenobarbitone/1,3‐ 15 N;2‐ 13 C phenobarbitone, N L /N H = 2.95; K aL / K aH = 0.44; %L/%H = 1.32, together with a change from one (saturable) to two (saturable + non‐saturable) families of albumin binding sites in the latter case. Contrasting with these data, no HSA binding isotope effect was observed on phenobarbitone C5 ethyl deuteration.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here